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The role of fructose-1,6-bisphosphate in 
metabolic regulation
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Metabolism and its regulation
Metabolism describes the biochemical processes that provide energy and building 
blocks for growth and maintenance of any living being, and thus resides at the core of 
life. Therefore, competitiveness and survival depends on a fast adaptation of metabolic 
operations in response to environmental changes. In the classical view, extra- and 
intracellular nutrients are sensed by specific transmembrane or intracellular receptors 
and the information is transferred to the cellular regulatory machineries. However, a 
novel concept of metabolic regulation has been proposed recently1,2. In this type of 
regulation the availability of extracellular nutrients is sensed indirectly via metabolic 
fluxes. Changes in the kind or concentration of available nutrients lead to alterations 
in intracellular metabolic fluxes, which in turn are sensed by flux sensing systems and 
allow the regulation of the metabolism accordingly3. 
Intracellular metabolic fluxes are sensed via so called flux signalling metabolites, i.e. 
metabolites, whose levels correlate with the flux through metabolic pathways1. In order 
to translate the metabolic flux into an action, the flux signals have to be converted 
to cellular regulation mechanisms. For instance, flux signalling metabolites bind and 
modulate the activity of transcription factors, which in turn modulate gene expression 
in a flux-dependent manner1.
One central metabolite indicated to act as a flux signalling metabolite is fructose-1,6-
bisphosphate (FBP), an intermediate of glycolysis. Over a wide range of glycolytic fluxes, 
which can be obtained, for instance, by growing cells on different carbon sources, this 
metabolite was found to correlate with the flux through glycolysis2. FBP is known to 
control the activity of transcription factors4,1, enzymes of glycolysis and gluconeogen-
esis5,6, as well as enzymes from other cellular processes. 
A metabolic flux-sensing system offers a robust type of metabolic regulation, since it 
allows cells to adapt their metabolism in response to a wide range of nutrients via a 
universal system and does not require the presence of nutrient-specific receptors. This 
concept was shown to be promising in a synthetic system7, and has been described as a 
metabolic regulatory system in Escherichia coli and Saccharomyces cerevisiae1–3,8.




FBP and its interactions
FBP correlates with glycolytic flux in a vast range of different organisms, such as E. coli, 
yeast and mammalian cells2,3,7,8. This suggests that the concept of flux-sensing and flux-
dependent regulation might have formed early in evolution. In order to understand the 
role of FBP in the flux-dependent regulation of metabolism, in the following, we review 
the current knowledge about the regulatory network of FBP with effectors involved in 
various cellular processes across different organisms. Specifically, interactions of FBP 
with enzymes, proteins involved in signalling pathways and transcription factors will be 
described here. 
Interactions of FBP with enzymes of the central carbon metabolism
As FBP is an intermediate of glycolysis, it is conceivable that FBP interacts with and 
influences the activity of enzymes of the central carbon metabolism. Therefore, we per-
formed a comprehensive literature search to generate an overview of the interactions 
between FBP and these enzymes (Figure 1). The global trend shows that FBP activates 
glycolytic enzymes and deactivates gluconeogenic enzymes. This is in agreement with 
the fact that under high glycolytic flux, the intracellular concentration of FBP is increased, 
resulting in repression of gluconeogenenic enzymes. Next to this, it has been reported 
that glycogen breakdown is inhibited by FBP, while glycogen synthesis is stimulated. 
Interactions of FBP with proteins of other metabolic processes
Besides enzymes of central carbon metabolism, FBP was found to modulate the activity 
of various enzymes involved in several other metabolic processes, such as amino acid 
synthesis, nucleotide synthesis and lipid metabolism (Table 1). In general, FBP has an 
activating influence on several enzymes involved in the lipid metabolism, but inhibits 
the activity of different enzymes responsible for nucleotide synthesis. 
Interactions of FBP with proteins from the mitochondrial respiration
It seems that FBP also has a role in controlling mitochondrial respiration. In S. cerevisiae, 
an increase in glycolytic flux induces a metabolic switch from respiration to fermenta-
tion, under aerobic conditions. This effect has also been observed in fast growing tumour 
cells, in highly proliferating non-tumour cells24, other Crabtree positive yeast strains, and 
some bacterial species24–26. In a recent study performed in S. cerevisiae, it was observed 
that FBP caused the inhibition of mitochondrial respiratory chain, resulting in a decrease 
in the respiration in these cells27. The same effect was also observed in isolated rat liver 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1. Overview of direct interacti ons of FBP with proteins from core carbon metabolism. In 
this fi gure the glycogen metabolism, glycolysis, gluconeogenesis, Calvin cycle and pentose phos-
phate pathway are shown. This fi gure was based on data from 12 organisms, including bacteria, 
yeast and mammals. References per enzyme can be found in the Supplementary Table 1. Pathway 
informati on is based on Berg et al9.




channels (MUC), responsible for the regulation of the oxidative phosphorylation, and 
to inhibit the rate of oxygen consumption in S. cerevisiae28. The respiration inhibition 
caused by FBP is targeted on two complexes of the mitochondrial respiratory chain: 
complex III and complex IV29. In mammals, the mitochondrial permeability transition 
triggers cell death programs, while closed MUC results in resistance to apoptosis. In 
addition, closed MUC inhibits apoptosis and results in unregulated cell growth, which 
may indicate a causal relationship between the immortalization of tumour cells and the 
cytoplasmic accumulation of FBP, as observed in hepatoma cells, Ehrlich ascites and 
yeast Crabtree positive cells27,28,30. Thus, the respiration inhibition caused by FBP, is 
connected to its role in regulating the mitochondrial unspecific channels. 
Interactions of FBP with transcription factors
FBP does not only regulate the activity of enzymes, but also of transcription factors 
(TFs), and thereby influences global gene expression. TFs bind to specific DNA operator 
sequences and activate or repress the expression of different genes. The activity of TFs 
can be regulated in different ways, for instance by posttranslational modification or 
interaction with ligands, which in turn lead to conformational changes that alter the 
affinity of the TFs for their target DNA operator31. 
FBP is known to regulate different transcription factors in various organisms. In 
Bacillus subtilis FBP is a well described regulator of the transcription factors ‘central 
glycolytic gene repressor’ (CggR) and ‘catabolite control protein A’ (CcpA)32, members 
of the LacI-GalR family of transcription regulators and pleiotropic control proteins for 
catabolite regulation of genes33. Next to the interaction of FBP with CggR and CcpA, it 
was suggested that FBP might also be involved in the transcriptional control of lactate 
dehydrogenase (LDH) and pyruvate formate-lyase in Streptococcus bovis34. It is worth 
to mention that the regulation of LDH expression was also indicated to be regulated by 
the TF CcpA34.
CggR regulates the expression of the gapA operon including several glycolytic genes. 
The interaction of CggR with the operon gapA represses transcription. However, the 
binding affinity of CggR to its target DNA is lowered upon binding of FBP, leading to 
enhanced trancription35,36. CggR contains two FBP binding sites with different affinities. 
Binding of FBP to the high affinity37,38 binding site causes a conformational change in 










































































































































































































































































































































































































































































































































































































































ity to the DNA operator site. Upon FBP binding to the lower affinity site, conformational 
changes within CggR reduce its affinity for the DNA operator37. 
CcpA modulates carbon catabolite regulation (CCR) either by repression or activation 
of over 300 target genes important for carbon metabolism in Bacillus subtilis, includ-
ing enzymes, transporters and several transcription factors39. CcpA is quite unusual 
amongst the LacI-GalR proteins, since it uses phosphoproteins from the HPr family as 
cofactor (either HPr or Chr). Although these phosphoproteins play an essential role in 
the regulation of this transcription factor, it was described that CcpA activity is regu-
lated by a combination of different signals, amongst others small molecules as FBP and 
glucose 6-phosphate (G6P). These metabolites function as corepressors to fine-tune the 
response of CcpA adjusted to the metabolic state of the cell. Studies have demonstrated 
that FBP and G6P stimulate specific binding of CcpA to its DNA operator39.
The transcription factor ‘catabolite repressor activator’ (Cra) from E. coli has also been 
suggested to be regulated by FBP40,41 as well as by fructose-1-phosphate (F1P)40,41. Cra, 
a member of the GalR-LacI superfamily of DNA-binding transcriptional regulators42, 
controls the transcription of several operons in enteric bacteria concerning carbon and 
energy metabolism. Among others it is responsible for the switch between glycolysis 
and gluconeogenesis by activating transcription of genes encoding biosynthetic and 
oxidative enzymes involved in the Krebs cycle, glyoxylate shunt and gluconeogenesis, 
and repressing transcription of genes involved in glycolysis40,41,43,44. Upon binding of 
F1P or FBP, Cra is displaced from the DNA binding sites, leading to an increase in the 
expression of glycolytic genes, and repression of the gluconeogenetic genes, which 
implies acceleration of the glycolytic fluxes4. 
The role of FBP in the regulation of Cra, however, is still a point of debate. Some studies 
claim that Cra is regulated by both F1P and FBP40,41, although these studies did not 
provide any experimental evidence to prove direct interaction between Cra and FBP40. 
DNA shift assay experiments with a labeled DNA fragment bearing a Cra operator 
sequence40,43 indicated binding of F1P, but not FBP. Other studies suggested that the 
in vitro response of Cra to FBP is due to a possible contamination of FBP with F1P40. 
However, some authors provided evidence that FBP is indeed an authentic regulator of 
Cra1,3,43. Up to now, the consensus is that F1P is the major agonist of Cra, and that FBP 








Interactions of FBP with proteins from signalling pathways
FBP has been found to play a role in the regulation of proteins from signalling pathways, 
for instance the epidermal growth factor receptor (EGFR) in triple-negative breast 
cancer cells (TNBC)45. EGFR is one of the major regulators of cell proliferation, survival 
and metabolism, and was found to be overexpressed in some types of cancer cells46. 
EGF signalling in TNBC cells activates the first step of glycolysis and slows down the 
last step of glycolysis, causing accumulation of metabolic intermediates within this 
pathway. Furthermore, FBP was found to bind directly to EGFR and enhances its activity, 
thereby increasing lactate excretion in TNBC, which eventually leads to inhibition of 
local cytotoxic T- cell activity. Since cytotoxic T-cells usually kill cancer cells, this would 
boost tumour growth45.
Recently, a new interaction between FBP and a signalling protein was identified. Ras 
proteins are small GTPases involved in cellular signal transduction. Once activated, Ras 
induces the activation of other proteins responsible for cell growth and differentiation. 
Mutated Ras genes, encoding overactive Ras proteins, are the most common oncogenes 
found in cancer cells47. Recently, it was found that FBP, in combination with guanine 
nucleotide, activates Ras in S. cerevisiae48. The authors describe a conserved mecha-
nism from yeast to mammals, where FBP binds the proteins Cdc25/Sos1, essential for 
the activation of Ras. This mechanism couples increased glycolytic flux to increased Ras 
proto-oncoprotein activity, and suggests that FBP can be involved in the regulation of 
cell proliferation in cancer cells48. 
Perturbations of intracellular FBP levels
The previous sections clearly indicates the importance of FBP as a flux-signalling 
metabolite. Therefore, the intracellular concentration of FBP plays an important role 
in regulatory mechanisms, which eventually could influence the fate of a cell. This sec-
tion provides an overview of phenotypic effects caused by altered FBP levels, reflecting 
altered glycolytic fluxes. Such information will provide us with a better understanding 
of FBP as a regulator of metabolism. Next to altering glycolytic fluxes (for instance, by 
use of different nutrients), different possibilities exist to manipulate cellular FBP levels: 
intracellular FBP levels can be perturbed by altering the expression or the activity of 
enzymes responsible for the production or the conversion of FBP into other metabo-
lites, or by the administration of FBP. 




Effects of increased FBP levels
Different studies involving the administration of FBP have been performed (Table 2). 
One of these studies used mammalian cell extracts to determine the effect of phos-
phorylated sugars in protein synthesis49. Cell extracts that are not supplemented with 
sugars show a decline in protein synthesis and a decrease in the amount of Met-tRNAf 
that binds to 40S ribosomal subunits. The addition of the phosphorylated sugars to 
these cell extracts, especially the addition of FBP, increased the binding activity of 
Met-tRNAf and allowed protein synthesis to resume. Another study analysed the 
intraperitoneal administration of galactosamine, known to cause reversible liver cell 
injuries, in combination with FBP, F1P or F6P50. The cell damages, monitored through 
changes in the serum enzymatic activities, were prevented only when galactosamine 
was co-administrated with FBP. Another study analyzed the effects of infusion of FBP via 
brachial vein in patients51. Here, they observed a slight decrease in heart and respira-
tory rate, an increase in inorganic phosphate and intra erythrocytic ATP concentration, 
as well as a decrease in plasma cholesterol and triglycerides. In this study the authors 
suggested that FBP was responsible for enhancing glycolysis. 
 
Table 2. Compilation of studies determining the effects of administration of FBP in different cell 
types. 





•  FBP stimulate protein synthesis in 






FBP in liver cells
•  This simultaneous administration 
prevented liver cell death.
Rat 50
Infusion of FBP via 
brachial vein 
•  Slight decrease in heart and respiratory 
rate.
•  Increase in inorganic phosphate and intra 
erythrocytic concentration of ATP.
•  Decrease in plasma cholesterol and 
triglycerides.
Humans 51
Table 3 summarizes the effects of knockout studies that result in increased intracel-
lular levels of FBP. The metabolic response due to the knockout of FBPase, the enzyme 








in A. thaliana, where two isoforms of the enzyme are present: one located in the cytosol 
and one inside the chloroplasts52. Knockout strains of each isoform and the correspond-
ing double mutants had an overall accumulation of FBP, the highest in the double 
deletion mutant. The absence of the cytosolic form resulted in accumulation of hexose 
phosphates and increased levels of starch. The knockout of the chloroplastic isoform 
had a profound effect on photosynthetic carbon metabolism and photorespiration, 
showed decreased levels of intracellular sugars, presented cell structural deficiencies 
and reduced plant growth. The double mutant showed a decline in sucrose content.
 
Table 3. Compilation of knockout studies determining the effects of high levels of FBP in different 
cell processes. 
Enzyme    Effects observed / Metabolic behaviour Organism Reference
Knockout
FBPase cytosolic • Accumulation of FBP and hexose 
phosphate.




FBPase chloropastic • Accumulation of FBP, triose-phosphates, 
and 3-phosphoglyceric acid.
• Decline in the levels of hexose-
phosphates and sugars, including sucrose, 
glucose, fructose, and trehalose (signalling) 
and maltose (starch degradation).





FBPase cytosolic and 
chloroplastic double 
mutant
• Higher increase in FBP accumulation.




Effects of decreased FBP levels
Intracellular levels of FBP can be decreased by enhancing the production of the enzymes 
aldolase or FBPase, by deletion of phosphofructokinase, or yet as a response to the 
processing of certain carbon sources. In Table 4 the effects of decreased intracellular 
levels of FBP, observed in distinct studies, are summarized. 
The overexpression of fructose-1,6-bisphosphate aldolase was studied in Streptococcus 
bovis34. The intracellular concentration of FBP considerably decreased as compared 
to the parental strain, whereas DHAP and GAP were slightly higher and the ratio of 
formate to lactate production was increased. The authors suggested that the synthesis 




of lactate dehydrogenase might be indirectly regulated by FBP, since the transcription 
of the ldh gene in S. bovis is presumed to be regulated by CcpA, a transcription factor 
known to be regulated by FBP in B. subtilis34. 
The overexpression of FBPase was studied in C. glutamicum53,54, where a decrease 
in FBP concentration was observed in cells growing on sucrose. In this study a signifi-
cant improvement in lysine production was observed, suggested to occur due to the 
redirection of carbon from glycolysis toward the PPP and an increased NADPH supply. 
Additionally these cells showed an increased growth rate, substrate uptake rate and 
biomass yield.
The overexpression of FBPase was also studied in pancreatic b cells, using mouse 
cells overexpressing human FBPase55. Lower levels of FBP and high levels of F6P were 
detected in cells growing in the presence of high glucose concentrations. A decrease in 
glucose utilization and energy production resulted in reduced insulin secretion of these 
cells. 
The effects of overexpressing FBPase were also analysed in hepatocellular carcinoma56. 
These cells are known to have lower expression of FBPase, which is associated with 
advanced tumour stage and higher tumour recurrence rates. Upon increased levels of 
FBPase, a decrease in the concentration of FBP and G6P was observed, and the tumour 
growth and the glucose uptake rate were inhibited. 
The recent study from Zhang and co-authors, explored the perturbations in the metabo-
lism as a response to different carbon sources57. In this study, performed in mouse 
embryo fibroblasts grown in low-glucose medium, decreased intracellular levels of FBP 
were found – consistent with the possibly decreased glycolytic flux. Under these condi-
tions, it was also observed that the enzyme AMP-activated protein kinase (AMPK) was 
activated. In order to test whether FBP was responsible for repressing the activation of 
AMPK, FBP was introduced into glucose-starved cells permeabilized with streptolysin O, 
and a decrease in AMPK activation was observed. 
Taken together, this overview shows that FBP regulates the activity of various proteins 
involved in a wide range of metabolic processes. Moreover, alterations in the intracel-
lular levels of FBP caused by perturbations, trigger metabolic alterations accordingly. 








the information gathered provide strong evidences that FBP is part of a metabolic flux 
sensing systems, where it acts as a signalling metabolite, regulating metabolism in a 
flux-dependent manner.
 
Table 4. Compilation of studies determining the effects of low levels of FBP in different cell pro-
cesses. 




Aldolase •  Lower FBP levels in cells growing on 
glucose.
•  DHAP and GAP levels were higher. 




FBPase •  Increase in FBP concentration in cell 
growing on sucrose.






• Lower FBP and ATP concentration.
•  Lower glucose utilization and energy 
production.





FBPase •  Lower FBP and G6P concentration.
•  Reduced glucose uptake rate, reduced 
glycolysis.







Aldolases •  AMPK activation even in glucose (i.e. high 
FBP levels).
•  FBP represses the activation of AMPK only 





Methods to study protein-metabolite interactions 
The interaction between metabolites and proteins is crucial for the regulation of 
distinct cellular processes. Identifying protein-(flux-signalling) metabolite interactions 
would provide essential information for understanding the downstream targets of flux 
signals. However, the vast chemical diversity of metabolites, combined with the fact 
that protein-metabolite interactions are often weak and transient, makes it extremely 
challenging to identify these interactions in a high throughput manner. Due to the lack 
of generally applicable systematic approaches, protein-metabolite interactions are 




often still identified using laborious in vitro activity assays, such as isothermal titration 
calorimetry, surface plasmon resonance and microscale thermophoresis. Recently, new 
methods that focus on the identification of protein-metabolite interactions in large-
scale have been developed, and some of them are described below. 
Methods such as thermal shift assays were originally designed to optimize recombinant 
protein stability, and are currently also used in high throughput screenings to identify 
new protein-metabolite interactions58. This technique detects differences in the stabil-
ity of proteins in the presence and absence of certain metabolites, by relying on the fact 
that protein structures are more stable when bound to their corresponding ligand59. 
Thermal shift assay, also known as differential scanning fluorimetry60,61 measures the 
increase in the fluorescence of the SYPRO orange dye, which interacts with hydropho-
bic parts of the proteins that are exposed upon temperature-induced denaturation. 
An interaction between the ligand and the protein of interest could increase thermal 
stability of the protein and thereby cause a delayed increase in fluorescence. Similar 
strategies, such as drug affinity responsive target stability (DARTS)62 and a proteomics 
method called stability of proteins by rates of oxidation (SPROX)63,64 have also being 
successfully used in the discovery of new interactions.
Another new strategy for the high throughout identification of interaction between 
metabolites and proteins is differential radial capillary action of ligand assay (DRaCALA), 
which requires radiolabeled metabolites.65 This method makes use of the fact that pro-
teins bind to nitrocellulose membranes and sequester radiolabeled metabolites, which 
are bound to the protein. One advantage of DRaCALA is that the raw cellular extracts 
containing an overexpressed protein of interest can be used without any further time-
consuming protein purification. However, the costs and availability of radiolabelled 
metabolites can limit the use of this approach. 
A recent method developed by Veyel and co-workers66 was based on the supposition 
that metabolites that interact with proteins form stable complexes that will fractionate 
together when a size separation method is applied. In this study, Arabidopsis thaliana 
cells were lysed and the soluble fraction, containing several proteins and metabolites, 
was separated by size using analytical ultracentrifugation or size filtration columns. 
Metabolites that were not bound to proteins were separated in the low molecular 
weight fraction. With this methodology, the authors were able to detect several metab-








with proteins, and can be recovered from protein-metabolite complexes. However, one 
limitation of this method is that the fractionation/separation of size is not sufficient 
to allow the specific identification between one protein and metabolite, since several 
proteins and several metabolites are analysed at the same time. 
A recent proof-of-concept study used ligand-detected nuclear magnetic resonance 
(NMR) spectroscopy to systematically identify protein-metabolite interactions67. A key 
advantage of this method is the possibility to test the impact of several metabolites 
simultaneously on one purified protein. Different NMR methods that detect signals from 
low molecular weight ligands and changes in their properties upon binding to a protein 
were tested. From the three NMR methods tested, two methods, water-ligand obser-
vation with gradient spectroscopy (WaterLOGSY) and diffusion and relaxation-edited 
NMR (T1hro relaxation), showed high sensitivity and robustness. These experiments 
identified most of the already known interactions, and also revealed new interaction 
partners. However, when increasing amounts of different metabolites were used in the 
analysis, a decrease in the detection of interactions was observed. A possible explana-
tion for that is that compounds may compete for the same binding site in the studied 
protein, increasing the likelihood of false negatives. 
A large-scale study developed by Li and colleagues68 used affinity protein purification 
and mass spectrometry (MS) assay for the identification of protein-metabolite interac-
tions in yeast. They focused on interactions of hydrophobic metabolites with kinases 
and proteins from the ergosterol pathway. Previously known interactions were iden-
tified, together with several new ones. Many enzymes from the ergosterol pathway 
were found to interact with sterol intermediates, suggesting a regulatory role of these 
molecules in this pathway. 
The use of FBP on a novel mass spectrometry based method for the identification of 
protein-metabolite interactions 
Feng and co-workers69 developed a method to identify condition-dependent in vivo 
protein-metabolite interactions by exploring the structural transitions of proteins in 
response to interaction with metabolites. In this method, proteins are first submitted 
to a digestion that cleaves off peptides present on the surface of the protein on a cer-
tain condition. Under a different condition, for instance, upon binding of a ligand, the 
conformation of the protein changes, and the same digestion results in the cleavage of 
different peptides. 




In this study, they focused on yeast metabolism, and investigated interactions that occur 
when cells grow on glucose or ethanol. The proteome of these cells were extracted 
under non-denaturing conditions, and submitted to double digestion. First, the samples 
were digested by limited proteolysis (LiP), which generates peptides according to the 
structural conformation of the proteins in the specific condition. The second digestion 
of the proteome was performed by full trypsinization. A control sample, subjected only 
to trypsinization, was also prepared. The peptides generated were submitted for analy-
sis using selected reaction monitoring (SRM)-MS. To identify structural alterations in 
the proteins due to different growth conditions, i.e. glucose or ethanol, the proteolytic 
patterns of the samples are compared after normalization with the control to correct for 
protein abundance between samples, incomplete trypsin specificity and endogenous 
protease cleavage. 
To validate the method, the authors used the protein pyruvate kinase (Cdc19), which is 
known to be activated by FBP, whose concentration is 100-fold higher in glucose than 
in ethanol. The analysis of SRM showed that the peptides with largest fold changes 
between the glucose and the ethanol condition were located in the active site and the 
FBP binding site. To determine whether the alterations observed were indeed due to 
changes in the concentration of FBP, this metabolite was added to lysates from ethanol 
growing culture. The proteolytic pattern of Cdc19 was reverted to the one observed 
when in presence of glucose, and the activity of the enzyme was recovered. These 
findings validated the method and confirmed that FBP was the responsible for the struc-
tural alterations observed between these two conditions. It was also observed that the 
addition of FBP to lysates from ethanol growing cultures altered the proteolytic pattern 
of about 70 other proteins, including proteins previously described to be regulated by 
FBP, as well as proteins that were not known to bind FBP, suggesting that this metabolite 
interacts and modulates the activity of these proteins. 
Aim and outline of this thesis
The aim of this thesis was to investigate the role of FBP as a flux-signaling metabolite 
and its participation in the regulation of the metabolism.
The MS-based method described above69, resulted in a list of suggested interactions 
between FBP and proteins whose structures suffered alterations when in presence of 








a biochemical approach to validate the interaction suggested between Hxk2 and FBP. 
Hxk2 was previously found to suffer conformational changes when in presence of FBP69. 
However, we did not find any indication of a direct interaction with FBP, therefore, we 
hypothesized that the structural alterations of Hxk2 could occur due to an interaction of 
FBP, by acting as a chelator, with metal ions that are important for the enzyme activity. 
In Chapter 3, seven other proteins that also showed structural changes in presence of 
FBP were biochemically tested to determine whether these changes were due to an 
interaction with FBP. Also for these proteins, our results indicate that there is no direct 
interaction of FBP with the studied proteins. In Chapter 4, we explored the role of FBP 
as a regulator of the transcription factors Cra and CggR. For CggR, we determined that 
millimolar concentrations of FBP are required to regulate the interaction of CggR with 
its DNA operator sequence. For Cra, we could finally establish that FBP does not interact 
with Cra, and do not regulate the activity of this transcription factor. In Chapter 5, we 
provide an outlook on the findings of this thesis, suggesting future research lines on the 
metabolism regulation.
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Supplementary Table 1: Interactions of FBP with enzymes from glycolysis, gluconeogenesis, gly-
cogen metabolism, Calvin cycle and pentose phosphate pathway. 
Enzyme Effect of FBP Organism Reference





Activates Pseudomonas aeruginosa 71,72
Pyruvate kinase Activates Yeast, E. coli, mammal 70,73,74 
Phosphoglucose 
isomerase















Activates Mung beans, barley 82,83
Malate dehydrogenase Inhibits Streptococcus faecalis 70,84 
Phosphoenol pyruvate 
carboxylase
Activates E. coli 85
Glycogen phosphorylase Inhibits Mouse 86
Phosphoglucomutase Activates Rabbit 87
ADP-glucose 
pyrophosphorylase
Activates E. coli, algae, plants 88–90
6-Phosphogluconate 
dehydrogenase
Inhibits Streptococcus faecalis, 

















Supplementary Table 1: Interactions of FBP with enzymes from glycolysis, gluconeogenesis, gly-
cogen metabolism, Calvin cycle and pentose phosphate pathway.  (continued)





Inhibits E. coli 95
32
